At the Winter Clinical Dermatology Meeting, April W. Armstrong, MD, MPH, professor and chief of dermatology at the UCLA ...
Pfizer Inc. (NYSE: PFE) today announced positive topline results from a Phase 2 study investigating tilrekimig (PF-07275315) ...
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, and Kelun-Biotech (6990.HK) today ...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) and Harbour BioMed (HKEX: 02142) today announced that the National Medical Products Administration (NMPA) ...
Dr Geng discusses his research from AAAAI Annual Meeting, which explored the relationship between atopic dermatitis and comorbid atopic conditions.
Everyday Health on MSN
The ‘Invisible’ Burden of Atopic Dermatitis: Why Your Dermatologist Needs to Hear About Your Mental Health
Many eczema patients skip the mental health talk. Learn how to discuss anxiety and depression with your dermatologist to unlock better treatment options and systemic therapies.
Chemical Holi colours can trigger rashes, acne, allergies and pigmentation. Know the most common post-Holi skin problems and expert-backed treatments for safe recovery.
Having spent years perfecting his swing on golf’s biggest stages, Max Homa is now channeling that same focus into making a meaningful impact off the course. The six-time PGA Tour winner is raising ...
Pfizer said a Phase 2 study of tilrekimig met its key goals in adults with moderate to severe atopic dermatitis, the most common form of eczema, and that it plans to accelerate the drug candidate into ...
Experts share pre-and-post Holi care tips to prevent contact dermatitis, dryness, hair breakage and scalp irritation caused ...
Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.
Pfizer Inc. (NYSE: PFE) today announced positive topline results from a Phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results